Antidepressive AgentsHypericumDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorElectroconvulsive TherapyDepressive DisorderSubstance-Related DisordersSubstance Abuse Treatment CentersAntidepressive Agents, TricyclicResidential TreatmentAntidepressive Agents, Second-GenerationFluoxetineEating DisordersSerotonin Uptake InhibitorsCitalopramDrug ResistanceTreatment OutcomeImipramineDesipramineSertralineAntipsychotic AgentsCognitive TherapyCyclohexanolsDepressionNortriptylineParoxetineAmitriptylineMianserinPsychiatric Status Rating ScalesPhenelzineTranylcypromineAdrenergic Uptake InhibitorsAnxiety DisordersBipolar DisorderMood DisordersSwimmingMonoamine Oxidase InhibitorsDiagnostic and Statistical Manual of Mental DisordersSerotonin Plasma Membrane Transport ProteinsSuicideBrain-Derived Neurotrophic FactorClomipramineBupropionBrainAnhedoniaStress, PsychologicalPsychotherapyFluvoxamineDysthymic DisorderSerotoninPersonality InventoryBehavior, AnimalHelplessness, LearnedComorbidityMental DisordersHippocampusReceptor, Serotonin, 5-HT1AElectroshockZimeldineAnalysis of VarianceAnxietyTime FactorsSeverity of Illness IndexAffectRats, Sprague-DawleyBiogenic MonoaminesPsychotropic DrugsDothiepinReceptors, Serotonin, 5-HT1TrazodoneReceptors, SerotoninHypothalamo-Hypophyseal SystemDouble-Blind MethodMaprotilineGyrus CinguliBuspironePharmacogeneticsAnti-Anxiety AgentsRisk FactorsSuicide, AttemptedTupaiaPrefrontal CortexPituitary-Adrenal SystemCorticosteroneInterview, PsychologicalDrug Therapy, CombinationMotor ActivityRecurrenceFollow-Up StudiesDose-Response Relationship, DrugAmygdalaDisease Models, AnimalFrontal LobeQuestionnairesRandomized Controlled Trials as TopicMedication AdherenceEmotionsExploratory BehaviorBenzodiazepinesNeurogenesis